Role of regulatory T cells in rheumatoid arthritis: facts and hypothesis

[1]  Miho Suzuki,et al.  Anti-IL-6 receptor antibody suppressed T cell activation by inhibiting IL-2 production and inducing regulatory T cells. , 2010, European journal of pharmacology.

[2]  P. Krammer,et al.  CD127(low/-) and FoxP3(+) expression levels characterize different regulatory T-cell populations in human peripheral blood. , 2010, The Journal of investigative dermatology.

[3]  S. Sakaguchi,et al.  Dynamics of peripheral tolerance and immune regulation mediated by Treg , 2009, European journal of immunology.

[4]  C. Benoist,et al.  Foxp3+ regulatory T cells: differentiation, specification, subphenotypes , 2009, Nature Immunology.

[5]  E. Shevach.  Mechanisms of foxp3+ T regulatory cell-mediated suppression. , 2009, Immunity.

[6]  M. A. Curotto de Lafaille,et al.  Natural and adaptive foxp3+ regulatory T cells: more of the same or a division of labor? , 2009, Immunity.

[7]  C. Riccardi,et al.  Identification of regulatory T cells in systemic lupus erythematosus. , 2009, Autoimmunity reviews.

[8]  M. Engström,et al.  FOXP3 expression in blood, synovial fluid and synovial tissue during inflammatory arthritis and intra-articular corticosteroid treatment , 2008, Annals of the rheumatic diseases.

[9]  M. Ehrenstein,et al.  Defects in CTLA-4 are associated with abnormal regulatory T cell function in rheumatoid arthritis , 2008, Proceedings of the National Academy of Sciences.

[10]  A. Vandenbark,et al.  Critical evaluation of regulatory T cells in autoimmunity: are the most potent regulatory specificities being ignored? , 2008, Immunology.

[11]  A. Ho,et al.  Reduced CD4+,CD25- T cell sensitivity to the suppressive function of CD4+,CD25high,CD127 -/low regulatory T cells in patients with active systemic lupus erythematosus. , 2008, Arthritis and rheumatism.

[12]  P. Lipsky,et al.  Clinical significance of increased CD4+CD25−Foxp3+ T cells in patients with new-onset systemic lupus erythematosus , 2008, Annals of the rheumatic diseases.

[13]  C. Kuo,et al.  The quantitative analysis of peripheral blood FOXP3‐expressing T cells in systemic lupus erythematosus and rheumatoid arthritis patients , 2007, European journal of clinical investigation.

[14]  S. Sipka,et al.  Measurement of natural (CD4+CD25high) and inducible (CD4+IL-10+) regulatory T cells in patients with systemic lupus erythematosus , 2007, Lupus.

[15]  P. Miossec,et al.  The role of T cells in rheumatoid arthritis: new subsets and new targets , 2007, Current opinion in rheumatology.

[16]  J. Pfeilschifter,et al.  Imbalance in distribution of functional autologous regulatory T cells in rheumatoid arthritis , 2007, Annals of the rheumatic diseases.

[17]  J. Bijlsma,et al.  Proinflammatory mediator-induced reversal of CD4+,CD25+ regulatory T cell-mediated suppression in rheumatoid arthritis. , 2007, Arthritis and rheumatism.

[18]  P. Lipsky,et al.  Deficient CD4+CD25high T Regulatory Cell Function in Patients with Active Systemic Lupus Erythematosus1 , 2007, The Journal of Immunology.

[19]  M. Ehrenstein,et al.  Anti–TNF-α therapy induces a distinct regulatory T cell population in patients with rheumatoid arthritis via TGF-β , 2007, The Journal of experimental medicine.

[20]  Y. Wang,et al.  Accumulation of FoxP3‐expressing CD4+CD25+ T cells with distinct chemokine receptors in synovial fluid of patients with active rheumatoid arthritis , 2007, Scandinavian journal of rheumatology.

[21]  P. Emery,et al.  Early rheumatoid arthritis is associated with a deficit in the CD4+CD25high regulatory T cell population in peripheral blood. , 2006, Rheumatology.

[22]  J. Bijlsma,et al.  Diversity of regulatory T cells to control arthritis. , 2006, Best practice & research. Clinical rheumatology.

[23]  H. Broxmeyer,et al.  Regulation of Trafficking Receptor Expression in Human Forkhead Box P3+ Regulatory T Cells1 , 2006, The Journal of Immunology.

[24]  P. Lipsky,et al.  TNF downmodulates the function of human CD4+CD25hi T-regulatory cells. , 2006, Blood.

[25]  J. Andreu,et al.  Decrease of regulatory T cells in patients with systemic lupus erythematosus , 2006, Annals of the rheumatic diseases.

[26]  P. Debré,et al.  Global Natural Regulatory T Cell Depletion in Active Systemic Lupus Erythematosus1 , 2005, The Journal of Immunology.

[27]  P. Campbell,et al.  JAK2 V617F Mutation Identifies a Biologically Distinct Subtype of Essential Thrombocythemia Which Resembles Polycythemia Vera. , 2005 .

[28]  L-L Fung,et al.  The Presence of Cytokine‐Suppressive CD4+CD25+ T Cells in the Peripheral Blood and Synovial Fluid of Patients with Rheumatoid Arthritis , 2005, Scandinavian journal of immunology.

[29]  R. González-Amaro,et al.  Immune effects of therapy with Adalimumab in patients with rheumatoid arthritis , 2005, Clinical and experimental immunology.

[30]  E. Mazzon,et al.  Role of glucocorticoid‐induced TNF receptor family gene (GITR) in collagen‐induced arthritis , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[31]  R. Toes,et al.  Effective treatment of collagen-induced arthritis by adoptive transfer of CD25+ regulatory T cells. , 2005, Arthritis and rheumatism.

[32]  M. Gershwin,et al.  Regulatory T cells: development, function and role in autoimmunity. , 2005, Autoimmunity reviews.

[33]  I. Rosner,et al.  Increased Spontaneous Apoptosis of CD4+CD25+ T Cells in Patients with Active Rheumatoid Arthritis Is Reduced by Infliximab , 2005, Annals of the New York Academy of Sciences.

[34]  X. Mariette,et al.  CD4 CD25high regulatory T cells are not impaired in patients with primary Sjögren's syndrome. , 2005, Journal of autoimmunity.

[35]  P. Isomäki,et al.  CD4+ CD25+ T cells with the phenotypic and functional characteristics of regulatory T cells are enriched in the synovial fluid of patients with rheumatoid arthritis , 2005, Clinical and experimental immunology.

[36]  A. Billiau,et al.  Defective CD4+CD25+ regulatory T cell functioning in collagen-induced arthritis: an important factor in pathogenesis, counter-regulated by endogenous IFN-γ , 2005, Arthritis research & therapy.

[37]  C. Akdis,et al.  Glucocorticoids upregulate FOXP3 expression and regulatory T cells in asthma. , 2004, The Journal of allergy and clinical immunology.

[38]  J. Bijlsma,et al.  CD4(+)CD25(+) regulatory T cells in rheumatoid arthritis: differences in the presence, phenotype, and function between peripheral blood and synovial fluid. , 2004, Arthritis and rheumatism.

[39]  J. Berthelot,et al.  Role for suppressor T cells in the pathogenesis of autoimmune diseases (including rheumatoid arthritis). Facts and hypotheses. , 2004, Joint, bone, spine : revue du rhumatisme.

[40]  D. Isenberg,et al.  Compromised Function of Regulatory T Cells in Rheumatoid Arthritis and Reversal by Anti-TNFα Therapy , 2004, The Journal of experimental medicine.

[41]  L-L Fung,et al.  Decreased CD4+CD25+ T Cells in Peripheral Blood of Patients with Systemic Lupus Erythematosus , 2004, Scandinavian journal of immunology.

[42]  J. Alcocer-Varela,et al.  Quantification of regulatory T cells in patients with systemic lupus erythematosus. , 2003, Journal of autoimmunity.

[43]  H. Ochs,et al.  Immune dysregulation, polyendocrinopathy, enteropathy, and X-linked inheritance (IPEX), a syndrome of systemic autoimmunity caused by mutations of FOXP3, a critical regulator of T-cell homeostasis , 2003, Current opinion in rheumatology.

[44]  R. Offringa,et al.  CD25+ cell depletion hastens the onset of severe disease in collagen-induced arthritis. , 2003, Arthritis and rheumatism.

[45]  A. Rudensky,et al.  Foxp3 programs the development and function of CD4+CD25+ regulatory T cells , 2003, Nature Immunology.

[46]  Jeffrey A. Bluestone,et al.  Opinion-regulatory lymphocytes: Natural versus adaptive regulatory T cells , 2003, Nature Reviews Immunology.

[47]  C. Baecher-Allan,et al.  Isolation and functional characterization of regulatory CD25brightCD4+ T cells from the target organ of patients with rheumatoid arthritis , 2003, European journal of immunology.

[48]  G. Schuler,et al.  Human CD4+CD25+ Regulatory, Contact-dependent T Cells Induce Interleukin 10–producing, Contact-independent Type 1-like Regulatory T Cells , 2002, The Journal of experimental medicine.

[49]  G. Schuler,et al.  Ex Vivo Isolation and Characterization of Cd4+Cd25+ T Cells with Regulatory Properties from Human Blood , 2001, The Journal of experimental medicine.

[50]  A. Bowcock,et al.  JM2, encoding a fork head-related protein, is mutated in X-linked autoimmunity-allergic disregulation syndrome. , 2000, The Journal of clinical investigation.

[51]  Edward Groth,et al.  Facts and hypotheses , 1999, Nature Biotechnology.

[52]  C. Riccardi,et al.  A new member of the tumor necrosis factor/nerve growth factor receptor family inhibits T cell receptor-induced apoptosis. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[53]  M. Toda,et al.  Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. , 1995, Journal of immunology.

[54]  D. Lawrence,et al.  CD4+CD25high T cell numbers are enriched in the peripheral blood of patients with rheumatoid arthritis. , 2008, Cellular immunology.

[55]  D. Ebo,et al.  Activated T cells complicate the identification of regulatory T cells in rheumatoid arthritis. , 2008, Cellular immunology.

[56]  A. Schuerwegh,et al.  Influence of anti-tumor necrosis factor therapy (Adalimumab) on regulatory T cells and dendritic cells in rheumatoid arthritis. , 2006, Clinical and experimental rheumatology.